MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
Insilico Medicine and Human Longevity announced a collaboration to co-develop what the companies describe as an AI foundation model focused on longevity science and aging research. The initiative will combine biological, clinical and longevity-related datasets to create AI models capable of supporting research into aging mechanisms, disease prevention, and healthspan extension. The goal is to accelerate scientific discovery and improve understanding of age-related conditions through large-scale computational analysis.
More
Posted by MedCloudInsider Editors on 05/26/20260 comments
Virtual Science AI, a medical intelligence platform company exclusively for life sciences, has launched Medical Competitor AI, an artificial intelligence–powered competitor activity tracking platform aimed at supporting pharmaceutical companies during product launches. The platform uses AI to monitor and analyze competitor activity, market developments, and commercial trends related to pharmaceutical assets. The goal is to help life sciences organizations respond more quickly to changing market conditions and improve launch planning strategies.
More
Posted by MedCloudInsider Editors on 05/18/20260 comments
Anthill, a transformational Content Excellence company focused on the life sciences industry, has launched Anthill Cloud, an AI-powered content platform designed for the U.S. life sciences market, targeting content creation, compliance, and operational workflows. As a connected cloud platform purpose-built for pharmaceutical, biotech, and MedTech commercial and medical teams, the platform integrates AI-powered content creation, modular authoring, and personalized HCP engagement into a single, compliance-ready ecosystem.
More
Posted by MedCloudInsider Editors on 05/18/20260 comments
Cellular Intelligence, an AI-native technology and biotechnology company, announced an agreement with Novo Nordisk to advance a clinical-stage cell therapy for Parkinson’s disease. The acquisition of Novo's cell-therapy program for Parkinson's will focus on developing therapies that use artificial intelligence to support research, optimization and clinical development processes. The effort targets Parkinson’s disease, a neurodegenerative disorder that affects millions worldwide and remains difficult to treat with existing therapies.
More
Posted by MedCloudInsider Editors on 05/11/20260 comments
The Coalition for Health AI (CHAI), a coalition driving responsible AI adoption in health sciences, has released a set of best practice guides aimed at supporting responsible use of artificial intelligence in Medicaid eligibility systems. The guidance is intended to help healthcare agencies and technology providers address issues such as fairness, transparency, accountability and oversight when deploying AI tools in public healthcare programs. The recommendations focus on ensuring that AI-driven eligibility decisions remain explainable and aligned with regulatory and ethical standards.
More
Posted by MedCloudInsider Editors on 05/11/20260 comments
Converge Bio, a developer of AI platforms for biotech and pharmaceutical companies, announced it is using its ConvergeAB platform, an antibody design and optimization solution, to improve the development of cancer treatments through artificial intelligence–driven design. The platform allows researchers to generate and refine therapeutic approaches using prompt-based interactions, enabling faster iteration in drug development.
More
Posted by MedCloudInsider Editors on 05/05/20260 comments
Conscientia Health, a healthcare organization delivering integrated health services through AI-powered telehealth and hybrid care models, has launched a virtual primary care platform designed to combine mental and physical healthcare services using artificial intelligence. The telehealth offering provides patients with access to integrated care through a single virtual environment, supporting services such as primary care consultations, mental health support, and ongoing care management. The platform uses AI to assist with patient engagement, care coordination, and data analysis. Powered by AI and advanced technology, the platform offers all-in-one integrative care features and is able to analyze integrated datasets, streamline workflows and enable real-time collaboration.
More
Posted by MedCloudInsider Editors on 04/27/20260 comments
Waltham Pet Science Institute has developed new artificial intelligence–supported risk assessment tool is being introduced to help detect early signs of periodontal disease in dogs. The system analyzes clinical and behavioral data to identify dogs at risk of developing gum disease, one of the most common health issues in companion animals, and predicts which dogs are most at risk. By providing early warnings, the tool is intended to enable veterinarians and pet owners to take preventive action before the condition progresses.
More
Posted by MedCloudInsider Editors on 04/27/20260 comments
10x Genomics, a life science technology company, has introduced Atera, a platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at scale. The platform combines hardware, software, and analytical tools to help researchers capture and interpret complex biological data at scale. Atera is intended to support applications such as genomics research, drug discovery, and disease analysis by providing more detailed insights into cellular behavior, marking a fundamental shift in how biology is analyzed and understood.
More
Posted by MedCloudInsider Editors on 04/21/20260 comments
Eclipsebio, a biotechnology company combining AI-powered sequence design, rapid prototyping, and sequencing-based analytics to support RNA drug development, has introduced eCOMPASS, an artificial intelligence–enabled platform designed to support RNA therapeutic development by integrating computational analysis with laboratory processes. The platform uses a lab-in-the-loop approach, combining AI models with experimental data to guide research and refine results in real time. The system is intended to help scientists design experiments, analyze outcomes, and iterate more efficiently during drug development. The platform combines the design, make, and test core capabilities to create a single integrated workflow.
More
Posted by MedCloudInsider Editors on 04/21/20260 comments
Core Solutions, a leader in AI-powered solutions for behavioral health and development, has introduced Cx360 Enterprise: The Intelligent Care Record, a platform designed to modernize data management and clinical workflows in behavioral health settings. The system integrates artificial intelligence to help providers capture, organize, and analyze patient information more effectively. The platform is intended to support clinical decision-making, streamline documentation, and improve coordination across care teams. Focused on behavioral health, the platform integrates AI to record and reflect on how care is delivered to individuals, providing healthcare workers with effective ways to manage and configure workflows as well as gain valuable and ethical insights.
More
Posted by MedCloudInsider Editors on 04/13/20260 comments
Ada Health, a clinical expertise and AI insights-driven service provider, announced it has secured a patent for a clinical layer designed to make large language models safer for use in healthcare applications. The technology, Ada's hybrid clinical AI architecture, acts as an intermediary between AI models and clinical use cases, applying medical validation, safety checks, and contextual controls to AI-generated outputs. The goal is to reduce risks associated with using general-purpose language models in clinical decision support and patient interactions. Ada's reasoning engine acts as a guardrail to improve accuracy and preserve rigor, offering a fully auditable clinical reasoning system.
More
Posted by MedCloudInsider Editors on 04/13/20260 comments